HC Wainwright & Co. Maintains Buy Rating for Biora Therapeutics: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Biora Therapeutics BIOR and lower its price target from $65.00 to $50.00. Shares of Biora…

Related Keywords

,Biora Therapeutics Inc ,Hc Wainwright Co ,Biora Therapeutics ,Therapeutics Inc ,News ,Ggregator ,Reaking News ,Uration ,Media ,